Marijuana
Autism
OMNI Medical Services, LLCPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Autism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lurasidone Sumitomo Pharma America, Inc. | Phase 3 | BB |
Everolimus Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Phase 2 | B |
Rapamycin Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Phase 2 | B |
Sertraline Holland Bloorview Kids Rehabilitation Hospital | Phase 2 | CCC |
Calcium folinate pentahydrate University of Arkansas | Phase 2 | CCC |
View all 10 →
Same molecule, other indications
Marijuana is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →